MRNA Moderna Inc
Company Analysis
Latest News
🟢 MRNA makes sharp 11.1% jump
MRNA is trading at $80.55, up 11.1% versus the comparison close of $72.50 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 MRNA is trading 5.1% up today driven by post-earnings repricing and pipeline optimism
MRNA is trading at $76.20 (+5.11%) as buyers extend the recent post-earnings rally. A recent analysis says the move is tied to Moderna’s first-quarter update,...
🟢 MRNA extends move to 5.4% up
MRNA is trading at $73.81, up 5.4% versus the comparison close of $70.03 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 MRNA continues rally on broader pipeline optimism and short squeeze
MRNA is trading 4% up at $72.84, extending a significant rally fueled by multiple catalysts. Investors are responding to recent positive regulatory momentum...
🟢 MRNA is trading 4.2% up today on regulatory progress for its flu vaccine
MRNA is trading 4.2% up now at $72.59, extending a sharp multi-day rally driven by regulatory progress on its mRNA flu vaccine, mFlusiva. • The move follows...
🟢 MRNA makes sharp 12.7% jump
MRNA is trading at $67.32, up 12.7% versus the comparison close of $59.75 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 MRNA is trading 5.5% up today after detailing expansion into autoimmune and cancer therapies
MRNA is trading 5.5% higher at $63.01 after investors reacted positively to the company's Science Day presentation detailing its expansion into autoimmune and...
Moderna expands into autoimmune and cancer therapies with new CAR-T program
Moderna hosted its Science Day on June 25, 2026, to detail updates to its research and early development pipeline. The company is moving mRNA-6007, a new in...
🟢 MRNA extends move to 6.7% up
MRNA is trading at $63.30, up 6.7% versus the comparison close of $59.34 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 MRNA is trading 4.8% up today, rebounding on continued FDA flu vaccine panel optimism
MRNA is trading 4.8% up at $62.17 as it rebounds from yesterday's sharp sell-off on continued optimism surrounding its flu vaccine pipeline. • The stock is...
🟢 Moderna Inc is trading 4.6% up today as FDA panel reviews flu vaccine and positive briefing documents emerge
• Moderna Inc. is trading 4.6% up today at $64.67, extending a powerful multi-day rally driven by recent company-specific developments. • The FDA's Vaccines...
🟢 Moderna Inc makes sharp 10.1% jump
MRNA is trading at $61.02, up 10.1% versus the comparison close of $55.40 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 Moderna Inc extends move to 5.1% up
MRNA is trading at $58.22, up 5.1% versus the comparison close of $55.40 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 Moderna Inc is trading 4.15% up today on new operating model, 2027-2028 product launch outlook, and favorable FDA flu vaccine data
Moderna Inc is trading 4.15% up now at $57.70, extending a sharp multi-day rally as investors react to the company’s new operating model, leadership...
Moderna Restructures Leadership for Future Product Launches
Moderna changed its operating model. The company prepares for multiple product launches. These launches are anticipated in 2027 and 2028. President Dr....
Moderna flu shot clears FDA review, despite gaps in clinical data
FDA staff found no major deficiencies in Moderna’s experimental mRNA flu vaccine, mFlusiva (mRNA-1010). Briefing documents released ahead of a June 18...
🟢 Moderna Inc makes sharp 10.1% jump
MRNA is trading at $57.37, up 10.1% versus the comparison close of $52.13 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 Moderna Inc is trading 5.9% up today as flu vaccine study shows superior immunity
Moderna Inc is trading 5.9% up now at $55.22 after a study published in Nature Immunology showed its investigational flu vaccine, mRNA-1010, generated broader...
Moderna Flu Vaccine Triggers Broader Immunity, Nature Study Shows
Moderna’s investigational mRNA-1010 vaccine generates a broader and more durable immune response than standard flu shots, according to a study published in...
🟢 Moderna Inc is trading 4% up today amid broad market surge and risk-on sentiment
Moderna Inc is trading 4% up at $51.91 as investors rotate into risk assets during a broad market surge. • The stock is outperforming recent levels despite a...